I agree that this site is using cookies. You can find further informations here.
X
Backes, Floor
223  results:
Search for persons X
?
1

Progression-free survival and safety at 3.5 years of follow..:

González-Martín, Antonio ; Pothuri, Bhavana ; Vergote, Ignace...
Future Oncology.  , 2024
Link: https://doi.org/10.2217/..
 
?
2

Retraction notice to "Cost-effectiveness of chemotherapy an..:

Riedinger, Courtney J. ; Barrington, David A. ; Nagel, Christa I....
Gynecologic Oncology.  183 (2024)  - p. R1 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Associations between race and ethnicity and treatment setti..:

Meade, Caitlin E. ; Sinnott, Jennifer A. ; Backes, Floor J....
Gynecologic Oncology.  188 (2024)  - p. 111-119 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Lunchbox trial: A randomized phase III trial of cisplatin a..:

Barlin, Joyce N. ; Mahar, Barb ; Ata, Ashar...
Gynecologic Oncology.  180 (2024)  - p. 63-69 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Phase II trial of pembrolizumab and epacadostat in recurren..:

Gien, Lilian T. ; Enserro, Danielle M. ; Block, Matthew S....
Gynecologic Oncology.  186 (2024)  - p. 61-68 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Does the choice of platinum doublet matter? A study to eval..:

Levine, Monica D. ; Wang, Heather ; Sriram, Bhargavi...
Gynecologic Oncology.  182 (2024)  - p. 51-56 , 2024
Link: https://doi.org/10.1016/..
 
?
7

RETRACTED: Cost-effectiveness of chemotherapy and dostarlim..:

Riedinger, Courtney J. ; Barrington, David A. ; Nagel, Christa I....
Gynecologic Oncology.  183 (2024)  - p. 78-84 , 2024
Link: https://doi.org/10.1016/..
 
?
8

ALDH1A1 promotes PARP inhibitor resistance by enhancing ret..:

Lavudi, Kousalya ; Banerjee, Ananya ; Li, Na...
npj Precision Oncology.  7 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
9

Less is more: clinical utility of postoperative laboratory ..:

Lightfoot, Michelle D.S. ; Felix, Ashley S. ; Calo, Corinne A....
American Journal of Obstetrics and Gynecology.  228 (2023)  1 - p. 59.e1-59.e13 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Varying presentations of immune checkpoint inhibitor-associ..:

Fox, Brandon ; Backes, Floor
Gynecologic Oncology Reports.  49 (2023)  - p. 101271 , 2023
Link: https://doi.org/10.1016/..
 
?
11

"More than a song and dance": Exploration of patient perspe..:

Morton, Molly ; Haight, Paulina J. ; Khadraoui, Wafa...
Gynecologic Oncology.  175 (2023)  - p. 81-87 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Epigenetic MMR defect identifies a risk group not accounted..:

Riedinger, Courtney J. ; Brown, Morgan ; Haight, Paulina J....
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
13

Role of minimally invasive surgery in gynecologic malignanc..:

, In: DiSaia and Creasman Clinical Gynecologic Oncology,
Cohen, Joshua G. ; Bixel, Kristin ; Backes, Floor J. - p. 594-614.e12 , 2023
Link: https://doi.org/10.1016/..
 
?
14

The impact of antibiotic and proton pump inhibitor use at t..:

Haight, Paulina J. ; Kistenfeger, Quinn ; Riedinger, Courtney J....
Gynecologic Oncology.  178 (2023)  - p. 14-22 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Pembrolizumab versus placebo in addition to carboplatin and..:

Eskander, Ramez ; Sill, Michael ; Beffa, Lindsey...
Gynecologic Oncology.  176 (2023)  - p. S42-S43 , 2023
Link: https://doi.org/10.1016/..
 
1-15